Predictors and Outcomes of Subclinical Inflammation in Pediatric Patients with Familial Mediterranean Fever: A Retrospective Cohort Study from a Single Center - Takeaways - MDSpire

Predictors and Outcomes of Subclinical Inflammation in Pediatric Patients with Familial Mediterranean Fever: A Retrospective Cohort Study from a Single Center

  • By

  • Onur Bahçeci

  • Fatma Aydin

  • Özen Taş Aslan

  • Doğacan Sarisoy

  • Elif Erorhan

  • Zeynep Birsin Özçakar

  • April 24, 2026

  • 0 min

Share

  • 1

    Familial Mediterranean fever (FMF) is a prevalent autoinflammatory condition primarily affecting Mediterranean ethnic groups.

  • 2

    Subclinical inflammation in FMF patients can lead to complications such as anemia, growth retardation, and AA amyloidosis.

  • 3

    Colchicine is the standard treatment for FMF, but 5-10% of patients show resistance, necessitating alternative therapies.

  • 4

    The study aimed to assess the frequency and risk factors of subclinical inflammation in pediatric FMF patients.

  • 5

    Patients with subclinical inflammation exhibited significant differences in clinical presentation and treatment response.

Original Source(s)

Predictors and Outcomes of Subclinical Inflammation in Pediatric Patients with Familial Mediterranean Fever: A Retrospective Cohort Study from a Single Center

  • by Onur Bahçeci, Fatma Aydin, Özen Taş Aslan, Doğacan Sarisoy, Elif Erorhan, Zeynep Birsin Özçakar

  • April 24, 2026

Related Content

Semaglutide Use Linked to Erythromelalgia Remission

Case details diagnostic workup and rapid symptom resolution following GLP-1 receptor agonist initiation.

AAO Updates HCQ Retinopathy Guidance

Updated recommendations emphasize dosing limits and screening for toxicity risk.

Enhancing Future Healthcare: The Importance of Oncofertility Education in German Medical Training Based on a Nationwide Survey of 346 Medical Students